Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.74338932 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.74338932 |
3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.47492178 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.32894119 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.32894119 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 6.03913970 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.98413650 |
8 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.47383898 |
9 | high-density lipoprotein particle remodeling (GO:0034375) | 5.37650533 |
10 | tryptophan catabolic process (GO:0006569) | 5.20436606 |
11 | indole-containing compound catabolic process (GO:0042436) | 5.20436606 |
12 | indolalkylamine catabolic process (GO:0046218) | 5.20436606 |
13 | glyoxylate metabolic process (GO:0046487) | 5.06750298 |
14 | bile acid biosynthetic process (GO:0006699) | 5.06704421 |
15 | kynurenine metabolic process (GO:0070189) | 5.06621662 |
16 | epoxygenase P450 pathway (GO:0019373) | 4.96513182 |
17 | regulation of cholesterol esterification (GO:0010872) | 4.95193400 |
18 | tryptophan metabolic process (GO:0006568) | 4.90270076 |
19 | reverse cholesterol transport (GO:0043691) | 4.85607924 |
20 | cysteine metabolic process (GO:0006534) | 4.85000013 |
21 | urea cycle (GO:0000050) | 4.84889926 |
22 | urea metabolic process (GO:0019627) | 4.84889926 |
23 | regulation of podosome assembly (GO:0071801) | 4.81081555 |
24 | regulation of vitamin metabolic process (GO:0030656) | 4.79774689 |
25 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.78781269 |
26 | sulfur amino acid catabolic process (GO:0000098) | 4.75251766 |
27 | negative regulation of fibrinolysis (GO:0051918) | 4.61100452 |
28 | protein-lipid complex remodeling (GO:0034368) | 4.58662168 |
29 | macromolecular complex remodeling (GO:0034367) | 4.58662168 |
30 | plasma lipoprotein particle remodeling (GO:0034369) | 4.58662168 |
31 | regulation of triglyceride catabolic process (GO:0010896) | 4.57694120 |
32 | negative regulation of cholesterol transport (GO:0032375) | 4.56842591 |
33 | negative regulation of sterol transport (GO:0032372) | 4.56842591 |
34 | omega-hydroxylase P450 pathway (GO:0097267) | 4.51944472 |
35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.50696152 |
36 | phospholipid efflux (GO:0033700) | 4.50416142 |
37 | regulation of fibrinolysis (GO:0051917) | 4.48315258 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.47190935 |
39 | protein carboxylation (GO:0018214) | 4.47190935 |
40 | nitrogen cycle metabolic process (GO:0071941) | 4.44315557 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.41264355 |
42 | cellular ketone body metabolic process (GO:0046950) | 4.40403306 |
43 | bile acid metabolic process (GO:0008206) | 4.39616562 |
44 | tyrosine metabolic process (GO:0006570) | 4.33620377 |
45 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.31961061 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.28543073 |
47 | aromatic amino acid family metabolic process (GO:0009072) | 4.24644589 |
48 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.24306948 |
49 | amino-acid betaine metabolic process (GO:0006577) | 4.21053712 |
50 | regulation of fever generation (GO:0031620) | 4.16919573 |
51 | regulation of protein activation cascade (GO:2000257) | 4.15493792 |
52 | alpha-amino acid catabolic process (GO:1901606) | 4.12075607 |
53 | acylglycerol homeostasis (GO:0055090) | 4.11276839 |
54 | triglyceride homeostasis (GO:0070328) | 4.11276839 |
55 | glutamate metabolic process (GO:0006536) | 4.11195140 |
56 | lysine catabolic process (GO:0006554) | 4.07236498 |
57 | lysine metabolic process (GO:0006553) | 4.07236498 |
58 | cellular biogenic amine catabolic process (GO:0042402) | 4.06749260 |
59 | amine catabolic process (GO:0009310) | 4.06749260 |
60 | drug catabolic process (GO:0042737) | 4.05771459 |
61 | complement activation, alternative pathway (GO:0006957) | 4.03950006 |
62 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01805940 |
63 | plasma lipoprotein particle clearance (GO:0034381) | 3.98803404 |
64 | cholesterol efflux (GO:0033344) | 3.98292469 |
65 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.88557748 |
66 | short-chain fatty acid metabolic process (GO:0046459) | 3.88477041 |
67 | cellular modified amino acid catabolic process (GO:0042219) | 3.88288626 |
68 | arginine metabolic process (GO:0006525) | 3.87957480 |
69 | regulation of chemokine biosynthetic process (GO:0045073) | 3.86800770 |
70 | cellular amino acid catabolic process (GO:0009063) | 3.85675569 |
71 | ketone body metabolic process (GO:1902224) | 3.84232332 |
72 | regulation of chronic inflammatory response (GO:0002676) | 3.83637600 |
73 | homocysteine metabolic process (GO:0050667) | 3.82945595 |
74 | regulation of complement activation (GO:0030449) | 3.82317780 |
75 | plasma lipoprotein particle assembly (GO:0034377) | 3.82219151 |
76 | positive regulation of heat generation (GO:0031652) | 3.81586797 |
77 | cellular glucuronidation (GO:0052695) | 3.81382048 |
78 | ethanol oxidation (GO:0006069) | 3.79714553 |
79 | acute-phase response (GO:0006953) | 3.79650211 |
80 | linoleic acid metabolic process (GO:0043651) | 3.79146426 |
81 | very long-chain fatty acid metabolic process (GO:0000038) | 3.78374852 |
82 | negative regulation of lipase activity (GO:0060192) | 3.75881555 |
83 | acetyl-CoA metabolic process (GO:0006084) | 3.70248725 |
84 | bile acid and bile salt transport (GO:0015721) | 3.69684593 |
85 | fibrinolysis (GO:0042730) | 3.69217526 |
86 | coenzyme catabolic process (GO:0009109) | 3.67524036 |
87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66050654 |
88 | indolalkylamine metabolic process (GO:0006586) | 3.63191555 |
89 | positive regulation of lipid catabolic process (GO:0050996) | 3.62193267 |
90 | urate metabolic process (GO:0046415) | 3.61203429 |
91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56930534 |
92 | phospholipid homeostasis (GO:0055091) | 3.53282785 |
93 | glycosphingolipid catabolic process (GO:0046479) | 3.53160985 |
94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52047175 |
95 | regulation of cholesterol homeostasis (GO:2000188) | 3.52001723 |
96 | serine family amino acid metabolic process (GO:0009069) | 3.51671349 |
97 | cholesterol homeostasis (GO:0042632) | 3.50675549 |
98 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.50214479 |
99 | virion attachment to host cell (GO:0019062) | 3.49967600 |
100 | adhesion of symbiont to host cell (GO:0044650) | 3.49967600 |
101 | heme transport (GO:0015886) | 3.49928274 |
102 | plasma lipoprotein particle organization (GO:0071827) | 3.49751078 |
103 | uronic acid metabolic process (GO:0006063) | 3.48001280 |
104 | glucuronate metabolic process (GO:0019585) | 3.48001280 |
105 | benzene-containing compound metabolic process (GO:0042537) | 3.47235358 |
106 | sterol homeostasis (GO:0055092) | 3.47054194 |
107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46927888 |
108 | regulation of immunoglobulin secretion (GO:0051023) | 3.43664478 |
109 | protein-lipid complex assembly (GO:0065005) | 3.43470312 |
110 | drug transmembrane transport (GO:0006855) | 3.42736129 |
111 | flavonoid metabolic process (GO:0009812) | 3.42709395 |
112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40888082 |
113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40888082 |
114 | activation of MAPKKK activity (GO:0000185) | 3.40712008 |
115 | organic acid catabolic process (GO:0016054) | 3.39148969 |
116 | carboxylic acid catabolic process (GO:0046395) | 3.39148969 |
117 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.38466326 |
118 | exogenous drug catabolic process (GO:0042738) | 3.38201180 |
119 | serine family amino acid biosynthetic process (GO:0009070) | 3.35784841 |
120 | lipoprotein metabolic process (GO:0042157) | 3.35569657 |
121 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.35498561 |
122 | regulation of mononuclear cell migration (GO:0071675) | 3.32881772 |
123 | imidazole-containing compound metabolic process (GO:0052803) | 3.32758051 |
124 | response to peptidoglycan (GO:0032494) | 3.31128809 |
125 | negative regulation of interleukin-12 production (GO:0032695) | 3.23293333 |
126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22728570 |
127 | drug metabolic process (GO:0017144) | 3.21417335 |
128 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.19269937 |
129 | glycolipid catabolic process (GO:0019377) | 3.17521854 |
130 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.16534637 |
131 | adhesion of symbiont to host (GO:0044406) | 3.15499262 |
132 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.14496854 |
133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.14352297 |
134 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.14084092 |
135 | oligosaccharide catabolic process (GO:0009313) | 3.11773063 |
136 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.09595177 |
137 | regulation of heat generation (GO:0031650) | 3.06155233 |
138 | complement activation (GO:0006956) | 3.03322593 |
139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98231391 |
140 | T-helper 1 type immune response (GO:0042088) | 2.97055065 |
141 | positive regulation of extracellular matrix organization (GO:1903055) | 2.95956266 |
142 | positive regulation of humoral immune response (GO:0002922) | 2.95335838 |
143 | angiotensin maturation (GO:0002003) | 2.91207889 |
144 | monocyte chemotaxis (GO:0002548) | 2.87835004 |
145 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.87601012 |
146 | negative regulation of hemostasis (GO:1900047) | 2.83743296 |
147 | negative regulation of blood coagulation (GO:0030195) | 2.83743296 |
148 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.82424562 |
149 | NIK/NF-kappaB signaling (GO:0038061) | 2.81663888 |
150 | protein activation cascade (GO:0072376) | 2.80946451 |
151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80571540 |
152 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.76043695 |
153 | regulation of growth of symbiont in host (GO:0044126) | 2.76043695 |
154 | negative regulation of growth of symbiont in host (GO:0044130) | 2.76043695 |
155 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.76043695 |
156 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.74533731 |
157 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.73435505 |
158 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.70675908 |
159 | regulation of humoral immune response (GO:0002920) | 2.70483917 |
160 | negative regulation of coagulation (GO:0050819) | 2.67525859 |
161 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.67459975 |
162 | ceramide catabolic process (GO:0046514) | 2.67292787 |
163 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.66614167 |
164 | complement activation, classical pathway (GO:0006958) | 2.66462794 |
165 | positive regulation of acute inflammatory response (GO:0002675) | 2.65536154 |
166 | response to protozoan (GO:0001562) | 2.65297643 |
167 | macrophage activation involved in immune response (GO:0002281) | 2.64452892 |
168 | myeloid dendritic cell differentiation (GO:0043011) | 2.64452329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.27921823 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45100788 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.60093135 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.37071140 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.18230124 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.96625289 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.08756940 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64583749 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.28879941 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.27730979 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23485642 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93106631 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.92827030 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69151159 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.68962992 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67191030 |
17 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.63120605 |
18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.63120605 |
19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.63120605 |
20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36581691 |
21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34326738 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23714609 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10812727 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95091237 |
25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91823182 |
26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78340891 |
27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.73484660 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72484756 |
29 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.67829068 |
30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66639736 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62202396 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61691071 |
33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57267752 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55720454 |
35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54566143 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53064634 |
37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52858387 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52642773 |
39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51559500 |
40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47484129 |
41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47140262 |
42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46407018 |
43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44401339 |
44 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.36377066 |
45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30948867 |
46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29453821 |
47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27305008 |
48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23523475 |
49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23383921 |
50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22194729 |
51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20005542 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19494883 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18722551 |
54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18150576 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17539406 |
56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14952609 |
57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12839060 |
58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10924920 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09482330 |
60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07765410 |
61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07572352 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07358260 |
63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06052319 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05126062 |
65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04877847 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04363188 |
67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03194899 |
68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03194899 |
69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03120370 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03063597 |
71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02317626 |
72 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02171580 |
73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02099256 |
74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01173148 |
75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00956955 |
76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99706174 |
77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99706174 |
78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99567743 |
79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99374971 |
80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99265294 |
81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99047422 |
82 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98561111 |
83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98264709 |
84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97997734 |
85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97723861 |
86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97639601 |
87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97375326 |
88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96099672 |
89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95887965 |
90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95729428 |
91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94692073 |
92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93232059 |
93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93150990 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91200478 |
95 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90826567 |
96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89726876 |
97 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.88866161 |
98 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.88774625 |
99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88354042 |
100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87710538 |
101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86627243 |
102 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86015240 |
103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85242251 |
104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84760909 |
105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84245090 |
106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83838458 |
107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83548410 |
108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83107923 |
109 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.82221833 |
110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82085569 |
111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81767179 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80474599 |
113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80074298 |
114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78488857 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78280269 |
116 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78040082 |
117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77872732 |
118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77142526 |
119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77097946 |
120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76924337 |
121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.76420128 |
122 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.75282210 |
123 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74783397 |
124 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.74530778 |
125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74317101 |
126 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.74271812 |
127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73945693 |
128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.73800082 |
129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73775031 |
130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73471588 |
131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72598178 |
132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.72382715 |
133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72226785 |
134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71975320 |
135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.71968111 |
136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71410761 |
137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.70952223 |
138 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.70251456 |
139 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70041973 |
140 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.69593780 |
141 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.68892641 |
142 | SPI1_23127762_ChIP-Seq_K562_Human | 0.68613304 |
143 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68154464 |
144 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.67087388 |
145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.65752226 |
146 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.63200769 |
147 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.63084136 |
148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61602034 |
149 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61396875 |
150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.61112303 |
151 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.60825447 |
152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60434893 |
153 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.60349291 |
154 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.60323350 |
155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60084361 |
156 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59880696 |
157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.59326063 |
158 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.58481838 |
159 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.58283518 |
160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57887709 |
161 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.57077966 |
162 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.57044711 |
163 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.56899386 |
164 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.56691583 |
165 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.56440963 |
166 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.56146444 |
167 | CJUN_26792858_Chip-Seq_BT549_Human | 0.56048307 |
168 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55967263 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.99300644 |
2 | MP0005360_urolithiasis | 7.25669219 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.01177783 |
4 | MP0005365_abnormal_bile_salt | 5.45753910 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.16515873 |
6 | MP0003303_peritoneal_inflammation | 4.47225307 |
7 | MP0010329_abnormal_lipoprotein_level | 3.41068473 |
8 | MP0003252_abnormal_bile_duct | 3.32175442 |
9 | MP0009840_abnormal_foam_cell | 3.31776079 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.13437126 |
11 | MP0005083_abnormal_biliary_tract | 2.81942705 |
12 | MP0005332_abnormal_amino_acid | 2.81344736 |
13 | MP0005058_abnormal_lysosome_morphology | 2.65284909 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.63026501 |
15 | MP0006082_CNS_inflammation | 2.62640377 |
16 | MP0009785_altered_susceptibility_to | 2.60668226 |
17 | MP0001666_abnormal_nutrient_absorption | 2.54536867 |
18 | MP0003436_decreased_susceptibility_to | 2.35390769 |
19 | MP0003195_calcinosis | 2.28228728 |
20 | MP0004510_myositis | 2.17415862 |
21 | MP0004019_abnormal_vitamin_homeostasis | 2.09396627 |
22 | MP0003868_abnormal_feces_composition | 2.07556321 |
23 | MP0002118_abnormal_lipid_homeostasis | 2.05694821 |
24 | MP0000343_altered_response_to | 1.96976027 |
25 | MP0003191_abnormal_cellular_cholesterol | 1.95639932 |
26 | MP0003724_increased_susceptibility_to | 1.94136838 |
27 | MP0000609_abnormal_liver_physiology | 1.82636925 |
28 | MP0002419_abnormal_innate_immunity | 1.81522718 |
29 | MP0005025_abnormal_response_to | 1.78923090 |
30 | MP0008004_abnormal_stomach_pH | 1.78525901 |
31 | MP0005387_immune_system_phenotype | 1.75180305 |
32 | MP0001790_abnormal_immune_system | 1.75180305 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.74355882 |
34 | MP0005166_decreased_susceptibility_to | 1.71570508 |
35 | MP0005000_abnormal_immune_tolerance | 1.67420273 |
36 | MP0004947_skin_inflammation | 1.63715208 |
37 | MP0010155_abnormal_intestine_physiology | 1.58975788 |
38 | MP0009697_abnormal_copulation | 1.56848446 |
39 | MP0003690_abnormal_glial_cell | 1.55895455 |
40 | MP0005451_abnormal_body_composition | 1.50990584 |
41 | MP0002254_reproductive_system_inflammat | 1.48301774 |
42 | MP0001835_abnormal_antigen_presentation | 1.47820967 |
43 | MP0005647_abnormal_sex_gland | 1.40724033 |
44 | MP0005319_abnormal_enzyme/_coenzyme | 1.39931379 |
45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39812382 |
46 | MP0001845_abnormal_inflammatory_respons | 1.34708185 |
47 | MP0002332_abnormal_exercise_endurance | 1.34097617 |
48 | MP0000604_amyloidosis | 1.33642216 |
49 | MP0001853_heart_inflammation | 1.33379660 |
50 | MP0003329_amyloid_beta_deposits | 1.31788614 |
51 | MP0002723_abnormal_immune_serum | 1.31489973 |
52 | MP0000566_synostosis | 1.29528041 |
53 | MP0001533_abnormal_skeleton_physiology | 1.28152848 |
54 | MP0003011_delayed_dark_adaptation | 1.27550270 |
55 | MP0002452_abnormal_antigen_presenting | 1.26929688 |
56 | MP0001800_abnormal_humoral_immune | 1.26509850 |
57 | MP0005671_abnormal_response_to | 1.26300245 |
58 | MP0002998_abnormal_bone_remodeling | 1.22919164 |
59 | MP0003448_altered_tumor_morphology | 1.18262907 |
60 | MP0009643_abnormal_urine_homeostasis | 1.18090500 |
61 | MP0001545_abnormal_hematopoietic_system | 1.14533679 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.14533679 |
63 | MP0001764_abnormal_homeostasis | 1.09471203 |
64 | MP0005408_hypopigmentation | 1.07973904 |
65 | MP0002405_respiratory_system_inflammati | 1.04785440 |
66 | MP0009333_abnormal_splenocyte_physiolog | 1.03508158 |
67 | MP0001501_abnormal_sleep_pattern | 1.02448424 |
68 | MP0009764_decreased_sensitivity_to | 1.02332167 |
69 | MP0005023_abnormal_wound_healing | 1.01754393 |
70 | MP0005167_abnormal_blood-brain_barrier | 0.99085583 |
71 | MP0002796_impaired_skin_barrier | 0.98938317 |
72 | MP0009384_cardiac_valve_regurgitation | 0.98270968 |
73 | MP0005084_abnormal_gallbladder_morpholo | 0.95382115 |
74 | MP0009278_abnormal_bone_marrow | 0.95036536 |
75 | MP0005670_abnormal_white_adipose | 0.92577090 |
76 | MP0008260_abnormal_autophagy | 0.92520989 |
77 | MP0001661_extended_life_span | 0.92083203 |
78 | MP0001851_eye_inflammation | 0.91980782 |
79 | MP0002420_abnormal_adaptive_immunity | 0.91340302 |
80 | MP0001819_abnormal_immune_cell | 0.90913928 |
81 | MP0003183_abnormal_peptide_metabolism | 0.90266546 |
82 | MP0003705_abnormal_hypodermis_morpholog | 0.87382901 |
83 | MP0009379_abnormal_foot_pigmentation | 0.85701858 |
84 | MP0000598_abnormal_liver_morphology | 0.85567129 |
85 | MP0005310_abnormal_salivary_gland | 0.84074661 |
86 | MP0003718_maternal_effect | 0.83465786 |
87 | MP0003091_abnormal_cell_migration | 0.83453757 |
88 | MP0000858_altered_metastatic_potential | 0.83152938 |
89 | MP0010368_abnormal_lymphatic_system | 0.78275662 |
90 | MP0003186_abnormal_redox_activity | 0.77325921 |
91 | MP0010307_abnormal_tumor_latency | 0.76817965 |
92 | MP0009763_increased_sensitivity_to | 0.76093044 |
93 | MP0005636_abnormal_mineral_homeostasis | 0.74793674 |
94 | MP0005409_darkened_coat_color | 0.74537358 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.74059483 |
96 | MP0003638_abnormal_response/metabolism_ | 0.73746852 |
97 | MP0000685_abnormal_immune_system | 0.73203468 |
98 | MP0004381_abnormal_hair_follicle | 0.71348194 |
99 | MP0002971_abnormal_brown_adipose | 0.70305331 |
100 | MP0010678_abnormal_skin_adnexa | 0.70065111 |
101 | MP0001216_abnormal_epidermal_layer | 0.69776667 |
102 | MP0002295_abnormal_pulmonary_circulatio | 0.68965882 |
103 | MP0003950_abnormal_plasma_membrane | 0.68418555 |
104 | MP0004885_abnormal_endolymph | 0.68272197 |
105 | MP0009642_abnormal_blood_homeostasis | 0.66929943 |
106 | MP0000920_abnormal_myelination | 0.66759453 |
107 | MP0000467_abnormal_esophagus_morphology | 0.65919609 |
108 | MP0005395_other_phenotype | 0.64823215 |
109 | MP0010234_abnormal_vibrissa_follicle | 0.62686379 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.62420677 |
111 | MP0000716_abnormal_immune_system | 0.62101888 |
112 | MP0004272_abnormal_basement_membrane | 0.61451396 |
113 | MP0005666_abnormal_adipose_tissue | 0.61393814 |
114 | MP0003879_abnormal_hair_cell | 0.61028101 |
115 | MP0000647_abnormal_sebaceous_gland | 0.61002281 |
116 | MP0005646_abnormal_pituitary_gland | 0.60588617 |
117 | MP0004130_abnormal_muscle_cell | 0.59927123 |
118 | MP0000639_abnormal_adrenal_gland | 0.58242796 |
119 | MP0003172_abnormal_lysosome_physiology | 0.57344667 |
120 | MP0002876_abnormal_thyroid_physiology | 0.56283257 |
121 | MP0008874_decreased_physiological_sensi | 0.55562795 |
122 | MP0000383_abnormal_hair_follicle | 0.55147327 |
123 | MP0005535_abnormal_body_temperature | 0.54646307 |
124 | MP0002078_abnormal_glucose_homeostasis | 0.53979833 |
125 | MP0003656_abnormal_erythrocyte_physiolo | 0.53287006 |
126 | MP0001756_abnormal_urination | 0.52493858 |
127 | MP0001879_abnormal_lymphatic_vessel | 0.52152700 |
128 | MP0002249_abnormal_larynx_morphology | 0.52129202 |
129 | MP0003453_abnormal_keratinocyte_physiol | 0.50628916 |
130 | MP0005334_abnormal_fat_pad | 0.49808646 |
131 | MP0003300_gastrointestinal_ulcer | 0.49572933 |
132 | MP0009053_abnormal_anal_canal | 0.49217232 |
133 | MP0005595_abnormal_vascular_smooth | 0.48989700 |
134 | MP0000249_abnormal_blood_vessel | 0.48309643 |
135 | MP0003941_abnormal_skin_development | 0.47702878 |
136 | MP0004782_abnormal_surfactant_physiolog | 0.47672866 |
137 | MP0004883_abnormal_blood_vessel | 0.47420457 |
138 | MP0002136_abnormal_kidney_physiology | 0.46949059 |
139 | MP0000462_abnormal_digestive_system | 0.46838583 |
140 | MP0008469_abnormal_protein_level | 0.46311235 |
141 | MP0002098_abnormal_vibrissa_morphology | 0.45448338 |
142 | MP0003075_altered_response_to | 0.44842341 |
143 | MP0005220_abnormal_exocrine_pancreas | 0.44718583 |
144 | MP0002822_catalepsy | 0.44196262 |
145 | MP0000230_abnormal_systemic_arterial | 0.43949830 |
146 | MP0005164_abnormal_response_to | 0.43483408 |
147 | MP0004185_abnormal_adipocyte_glucose | 0.42266763 |
148 | MP0005248_abnormal_Harderian_gland | 0.40067622 |
149 | MP0005165_increased_susceptibility_to | 0.39287529 |
150 | MP0002090_abnormal_vision | 0.39211161 |
151 | MP0004147_increased_porphyrin_level | 0.39204316 |
152 | MP0005266_abnormal_metabolism | 0.38508453 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.17021024 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.75674571 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.61753484 |
4 | Intrahepatic cholestasis (HP:0001406) | 6.47662112 |
5 | Xanthomatosis (HP:0000991) | 6.37837327 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.06939622 |
7 | Hyperlipoproteinemia (HP:0010980) | 6.01550976 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.96746626 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 5.65617960 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 5.22055293 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.22055293 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.22055293 |
13 | Hypolipoproteinemia (HP:0010981) | 4.66303983 |
14 | Hyperammonemia (HP:0001987) | 4.38974263 |
15 | Ketosis (HP:0001946) | 4.37795132 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.37205311 |
17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31273056 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.14085312 |
19 | Epidermoid cyst (HP:0200040) | 4.12108074 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09228927 |
21 | Hyperglycinemia (HP:0002154) | 4.07440180 |
22 | Hyperglycinuria (HP:0003108) | 4.06646460 |
23 | Abnormality of glycine metabolism (HP:0010895) | 4.05099390 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.05099390 |
25 | Vacuolated lymphocytes (HP:0001922) | 4.03823707 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.01001299 |
27 | Complement deficiency (HP:0004431) | 3.99732203 |
28 | Abnormality of methionine metabolism (HP:0010901) | 3.94331635 |
29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93442651 |
30 | Loss of speech (HP:0002371) | 3.92233955 |
31 | Joint hemorrhage (HP:0005261) | 3.91763854 |
32 | Hypoglycemic coma (HP:0001325) | 3.85751849 |
33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74754465 |
34 | Increased cerebral lipofuscin (HP:0011813) | 3.53350926 |
35 | Hypercholesterolemia (HP:0003124) | 3.49746963 |
36 | Fat malabsorption (HP:0002630) | 3.47214267 |
37 | Delayed CNS myelination (HP:0002188) | 3.43011338 |
38 | Ketoacidosis (HP:0001993) | 3.23178158 |
39 | Abnormality of macrophages (HP:0004311) | 3.21791480 |
40 | Interstitial pulmonary disease (HP:0006530) | 3.15190052 |
41 | Nephritis (HP:0000123) | 3.11691429 |
42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11647125 |
43 | Disinhibition (HP:0000734) | 3.11214768 |
44 | Mutism (HP:0002300) | 3.05400046 |
45 | Abnormality of purine metabolism (HP:0004352) | 3.01644342 |
46 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98849452 |
47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.97540584 |
48 | Nuclear cataract (HP:0100018) | 2.97510301 |
49 | Myocardial infarction (HP:0001658) | 2.96432971 |
50 | Optic neuritis (HP:0100653) | 2.96116447 |
51 | Retrobulbar optic neuritis (HP:0100654) | 2.96116447 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95279081 |
53 | Orchitis (HP:0100796) | 2.94317143 |
54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.93259672 |
55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86644652 |
56 | Axonal loss (HP:0003447) | 2.84591774 |
57 | Malnutrition (HP:0004395) | 2.81855304 |
58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81053502 |
59 | Dysostosis multiplex (HP:0000943) | 2.80882276 |
60 | Increased serum ferritin (HP:0003281) | 2.78290794 |
61 | Esophageal varix (HP:0002040) | 2.78210728 |
62 | Hypoglycemic seizures (HP:0002173) | 2.78046052 |
63 | Hyperbilirubinemia (HP:0002904) | 2.76947461 |
64 | Nausea (HP:0002018) | 2.74728986 |
65 | Abnormality of complement system (HP:0005339) | 2.72898304 |
66 | Eczematoid dermatitis (HP:0000976) | 2.68505047 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.65589426 |
68 | Gout (HP:0001997) | 2.64531472 |
69 | Abnormality of serum amino acid levels (HP:0003112) | 2.61865726 |
70 | Vascular calcification (HP:0004934) | 2.61542996 |
71 | Steatorrhea (HP:0002570) | 2.58378919 |
72 | Spontaneous abortion (HP:0005268) | 2.58293255 |
73 | Myositis (HP:0100614) | 2.54495506 |
74 | Hepatocellular carcinoma (HP:0001402) | 2.51274200 |
75 | Metabolic acidosis (HP:0001942) | 2.51100385 |
76 | Stomatitis (HP:0010280) | 2.49897646 |
77 | Hemorrhage of the eye (HP:0011885) | 2.48901613 |
78 | Apathy (HP:0000741) | 2.48228992 |
79 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45103875 |
80 | Confusion (HP:0001289) | 2.44599176 |
81 | Neurofibrillary tangles (HP:0002185) | 2.44498357 |
82 | Spastic diplegia (HP:0001264) | 2.43028912 |
83 | Lethargy (HP:0001254) | 2.41727887 |
84 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.39794633 |
85 | Purpura (HP:0000979) | 2.39683052 |
86 | Skin nodule (HP:0200036) | 2.39562050 |
87 | Diminished motivation (HP:0000745) | 2.38851666 |
88 | Gangrene (HP:0100758) | 2.36139460 |
89 | Recurrent abscess formation (HP:0002722) | 2.34885388 |
90 | Mediastinal lymphadenopathy (HP:0100721) | 2.31557302 |
91 | Parakeratosis (HP:0001036) | 2.31522738 |
92 | Recurrent bacterial skin infections (HP:0005406) | 2.31026650 |
93 | Abnormality of secondary sexual hair (HP:0009888) | 2.28440964 |
94 | Abnormality of the axillary hair (HP:0100134) | 2.28440964 |
95 | Cardiovascular calcification (HP:0011915) | 2.27307388 |
96 | Irritability (HP:0000737) | 2.26782169 |
97 | Dicarboxylic aciduria (HP:0003215) | 2.25761254 |
98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25761254 |
99 | Polygenic inheritance (HP:0010982) | 2.24431198 |
100 | Abnormality of iron homeostasis (HP:0011031) | 2.23910953 |
101 | Peripheral demyelination (HP:0011096) | 2.22547426 |
102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21860970 |
103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21860970 |
104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21860970 |
105 | Amyloidosis (HP:0011034) | 2.20350832 |
106 | Neuronal loss in central nervous system (HP:0002529) | 2.19106207 |
107 | Prolonged neonatal jaundice (HP:0006579) | 2.18327449 |
108 | Tetraparesis (HP:0002273) | 2.17435407 |
109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16918993 |
110 | Elevated alkaline phosphatase (HP:0003155) | 2.15800316 |
111 | Enlarged kidneys (HP:0000105) | 2.12408442 |
112 | Cholecystitis (HP:0001082) | 2.12405230 |
113 | Abnormal gallbladder physiology (HP:0012438) | 2.12405230 |
114 | Abnormality of the periventricular white matter (HP:0002518) | 2.11958464 |
115 | Paralysis (HP:0003470) | 2.10413030 |
116 | Pseudobulbar signs (HP:0002200) | 2.08674225 |
117 | Sensorimotor neuropathy (HP:0007141) | 2.07033797 |
118 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04526450 |
119 | Mucopolysacchariduria (HP:0008155) | 2.04526450 |
120 | Metaphyseal irregularity (HP:0003025) | 2.04463352 |
121 | Abnormality of proline metabolism (HP:0010907) | 2.03438526 |
122 | Hydroxyprolinuria (HP:0003080) | 2.03438526 |
123 | Bone pain (HP:0002653) | 2.03431983 |
124 | Joint swelling (HP:0001386) | 2.01569152 |
125 | Alkalosis (HP:0001948) | 2.00581862 |
126 | Late onset (HP:0003584) | 2.00259870 |
127 | Keratoconjunctivitis sicca (HP:0001097) | 1.99570629 |
128 | Back pain (HP:0003418) | 1.98968507 |
129 | Hypophosphatemic rickets (HP:0004912) | 1.98894236 |
130 | Generalized aminoaciduria (HP:0002909) | 1.98328396 |
131 | Pancreatitis (HP:0001733) | 1.98021986 |
132 | Neonatal onset (HP:0003623) | 1.97456870 |
133 | Mitral stenosis (HP:0001718) | 1.97068104 |
134 | Abnormal gallbladder morphology (HP:0012437) | 1.96682627 |
135 | Rickets (HP:0002748) | 1.96402701 |
136 | Vomiting (HP:0002013) | 1.94053864 |
137 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93958330 |
138 | Increased purine levels (HP:0004368) | 1.93561890 |
139 | Hyperuricemia (HP:0002149) | 1.93561890 |
140 | Acanthocytosis (HP:0001927) | 1.92399813 |
141 | Conjunctival telangiectasia (HP:0000524) | 1.92194101 |
142 | Dementia (HP:0000726) | 1.91867110 |
143 | Status epilepticus (HP:0002133) | 1.91762946 |
144 | Bifid scrotum (HP:0000048) | 1.91669915 |
145 | Cerebral edema (HP:0002181) | 1.90500402 |
146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89306821 |
147 | Glomerulonephritis (HP:0000099) | 1.89114788 |
148 | Cerebral inclusion bodies (HP:0100314) | 1.87675904 |
149 | Cholelithiasis (HP:0001081) | 1.86135178 |
150 | Hypochromic microcytic anemia (HP:0004840) | 1.85831069 |
151 | Symptomatic seizures (HP:0011145) | 1.83933317 |
152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82869891 |
153 | Widely patent fontanelles and sutures (HP:0004492) | 1.81862506 |
154 | Abnormal cartilage morphology (HP:0002763) | 1.79587217 |
155 | Hypophosphatemia (HP:0002148) | 1.78868499 |
156 | Pulmonary infiltrates (HP:0002113) | 1.77321294 |
157 | Polycythemia (HP:0001901) | 1.77308954 |
158 | Pulmonary embolism (HP:0002204) | 1.75952606 |
159 | Memory impairment (HP:0002354) | 1.75658988 |
160 | Abnormality of vitamin metabolism (HP:0100508) | 1.74572589 |
161 | Abnormality of urine glucose concentration (HP:0011016) | 1.72933168 |
162 | Glycosuria (HP:0003076) | 1.72933168 |
163 | Thrombophlebitis (HP:0004418) | 1.72361289 |
164 | Pathologic fracture (HP:0002756) | 1.71464422 |
165 | Opisthotonus (HP:0002179) | 1.69995296 |
166 | Brushfield spots (HP:0001088) | 1.69048934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 5.43681687 |
2 | TSSK6 | 4.87002548 |
3 | BCKDK | 4.18496424 |
4 | SIK1 | 3.77258995 |
5 | RIPK1 | 3.64869308 |
6 | NME2 | 3.31738191 |
7 | KDR | 3.12077989 |
8 | FGFR4 | 2.92838448 |
9 | TAOK2 | 2.83326950 |
10 | FGFR2 | 2.73884854 |
11 | DDR2 | 2.71235431 |
12 | TBK1 | 2.55832325 |
13 | TYRO3 | 2.55494414 |
14 | GRK7 | 2.55274728 |
15 | MATK | 2.42317386 |
16 | ERBB4 | 2.39330079 |
17 | PRPF4B | 2.33244247 |
18 | INSRR | 2.32582082 |
19 | TNIK | 2.26974795 |
20 | PIM2 | 2.05076239 |
21 | PDGFRA | 2.04125610 |
22 | MAP2K4 | 1.96617561 |
23 | EPHA4 | 1.91569142 |
24 | EPHB1 | 1.90955363 |
25 | IKBKB | 1.81421729 |
26 | TIE1 | 1.80504268 |
27 | ERN1 | 1.78089416 |
28 | IRAK4 | 1.70633801 |
29 | PRKAA2 | 1.65021521 |
30 | BLK | 1.62457218 |
31 | ACVR1B | 1.57205983 |
32 | LATS1 | 1.55870726 |
33 | BMPR2 | 1.54242304 |
34 | IKBKE | 1.52298631 |
35 | STK39 | 1.49456764 |
36 | NTRK2 | 1.45994920 |
37 | MAP3K2 | 1.41346857 |
38 | TRIB3 | 1.37567557 |
39 | OXSR1 | 1.34410561 |
40 | AKT3 | 1.32504302 |
41 | MAPK12 | 1.31180412 |
42 | MST1R | 1.30806384 |
43 | LATS2 | 1.27565136 |
44 | MUSK | 1.27331431 |
45 | RIPK4 | 1.26710078 |
46 | GRK1 | 1.25276956 |
47 | PDGFRB | 1.24667038 |
48 | STK24 | 1.24266214 |
49 | CDC42BPA | 1.22776874 |
50 | CHUK | 1.20682397 |
51 | IRAK2 | 1.20424160 |
52 | TYK2 | 1.16195616 |
53 | EPHB2 | 1.12270684 |
54 | ABL2 | 1.11787296 |
55 | TAOK3 | 1.11293543 |
56 | IRAK1 | 1.08422082 |
57 | PDK2 | 1.07494809 |
58 | FES | 1.07114064 |
59 | PRKCQ | 1.07014748 |
60 | PTK6 | 1.05177688 |
61 | CSK | 1.05080559 |
62 | ICK | 1.03714033 |
63 | KSR2 | 1.03408789 |
64 | PIM1 | 1.02777529 |
65 | MAP3K5 | 1.02263500 |
66 | GSK3A | 1.01833160 |
67 | PKN2 | 1.01400701 |
68 | MAP3K1 | 0.99488338 |
69 | MAP3K3 | 0.97937829 |
70 | NLK | 0.97115784 |
71 | CAMK1D | 0.96031013 |
72 | FRK | 0.92193881 |
73 | ERBB2 | 0.91965465 |
74 | MAP4K1 | 0.90999634 |
75 | MAP3K7 | 0.90616897 |
76 | NUAK1 | 0.90249476 |
77 | MET | 0.89398864 |
78 | PRKCZ | 0.87112100 |
79 | MAPK7 | 0.84223645 |
80 | MAPK15 | 0.83491856 |
81 | CAMK1G | 0.82567217 |
82 | PTK2 | 0.80080903 |
83 | PIK3CG | 0.79497785 |
84 | MAP3K6 | 0.79070873 |
85 | ARAF | 0.77955773 |
86 | MAPK11 | 0.77308936 |
87 | CSNK1G2 | 0.74628258 |
88 | RET | 0.73768620 |
89 | PAK6 | 0.73452768 |
90 | CSNK1G1 | 0.73367786 |
91 | JAK2 | 0.72084129 |
92 | FGR | 0.71834261 |
93 | NTRK1 | 0.71003821 |
94 | PKN1 | 0.70227985 |
95 | PAK3 | 0.69597925 |
96 | MAP2K1 | 0.69141019 |
97 | IGF1R | 0.68903297 |
98 | SGK223 | 0.68411465 |
99 | SGK494 | 0.68411465 |
100 | EPHA3 | 0.68217678 |
101 | MAP3K13 | 0.67988687 |
102 | FGFR3 | 0.63395139 |
103 | PRKACG | 0.63306441 |
104 | JAK3 | 0.62021428 |
105 | MAPK4 | 0.61787072 |
106 | ROCK1 | 0.59706496 |
107 | PRKAA1 | 0.59590838 |
108 | MAP2K3 | 0.57043288 |
109 | GRK6 | 0.56416363 |
110 | BMX | 0.53223779 |
111 | PDPK1 | 0.52913221 |
112 | STK10 | 0.52690419 |
113 | WNK4 | 0.52470940 |
114 | ADRBK2 | 0.51783085 |
115 | CASK | 0.51292244 |
116 | PTK2B | 0.50163394 |
117 | MYLK | 0.49463279 |
118 | MAP3K9 | 0.49091714 |
119 | CSNK1A1L | 0.49091701 |
120 | PRKCG | 0.48730532 |
121 | DAPK2 | 0.48613091 |
122 | ZAP70 | 0.47653735 |
123 | CSNK1G3 | 0.47540504 |
124 | CAMK2G | 0.47294259 |
125 | DYRK3 | 0.47225172 |
126 | PAK4 | 0.45614530 |
127 | MAP2K2 | 0.45518097 |
128 | NEK9 | 0.45458283 |
129 | PBK | 0.45118078 |
130 | CDK6 | 0.45017399 |
131 | TAOK1 | 0.44948688 |
132 | FER | 0.44360748 |
133 | MAPK13 | 0.43669395 |
134 | INSR | 0.43479707 |
135 | PRKCA | 0.43264014 |
136 | PAK2 | 0.42689158 |
137 | TESK2 | 0.41691354 |
138 | MAP3K11 | 0.41666756 |
139 | LYN | 0.41229953 |
140 | TGFBR2 | 0.40437912 |
141 | MAP2K6 | 0.40031581 |
142 | MOS | 0.39959540 |
143 | MAP3K14 | 0.39162710 |
144 | MARK3 | 0.34627604 |
145 | EGFR | 0.33781677 |
146 | JAK1 | 0.31218707 |
147 | CSF1R | 0.28280858 |
148 | NEK6 | 0.24389463 |
149 | RPS6KA1 | 0.23874841 |
150 | CAMKK2 | 0.23195259 |
151 | TXK | 0.18842279 |
152 | ABL1 | 0.18384481 |
153 | LCK | 0.15666853 |
154 | DAPK3 | 0.14706269 |
155 | DYRK1B | 0.13671130 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94009192 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.89706630 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.44786708 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22111168 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08748790 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97292676 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54288509 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45759972 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40170006 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36686844 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36251971 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32417228 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24406961 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20839595 |
15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.15407848 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09888523 |
17 | Pertussis_Homo sapiens_hsa05133 | 2.07766301 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07170874 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04591569 |
20 | Peroxisome_Homo sapiens_hsa04146 | 2.00484220 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99544655 |
22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99216817 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.98762099 |
24 | Asthma_Homo sapiens_hsa05310 | 1.92728175 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90070476 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89320263 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.88177798 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84581612 |
29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81783518 |
30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79239956 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78392887 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.76969754 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69516546 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68146852 |
35 | Malaria_Homo sapiens_hsa05144 | 1.66699759 |
36 | Allograft rejection_Homo sapiens_hsa05330 | 1.64160534 |
37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63409042 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63149223 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59099442 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55411450 |
41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54840614 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54201008 |
43 | Lysosome_Homo sapiens_hsa04142 | 1.51547157 |
44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51214447 |
45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50524445 |
46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45918591 |
47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44827309 |
48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38970576 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38689748 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37174356 |
51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33138508 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32798747 |
53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28221476 |
54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27238299 |
55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26937404 |
56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26218465 |
57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24394812 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24202553 |
59 | Salmonella infection_Homo sapiens_hsa05132 | 1.23790010 |
60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21228934 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20996059 |
62 | Influenza A_Homo sapiens_hsa05164 | 1.19898671 |
63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13428222 |
64 | ABC transporters_Homo sapiens_hsa02010 | 1.13089422 |
65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12598385 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.12515602 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12368784 |
68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11763149 |
69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11249555 |
70 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10967295 |
71 | Tuberculosis_Homo sapiens_hsa05152 | 1.10241842 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06153350 |
73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04113561 |
74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03808591 |
75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03439593 |
76 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02897446 |
77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98616440 |
78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98029963 |
79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96812784 |
80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96623150 |
81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95538679 |
82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93010418 |
83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89394201 |
84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86489721 |
85 | Lysine degradation_Homo sapiens_hsa00310 | 0.86149297 |
86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84604780 |
87 | Amoebiasis_Homo sapiens_hsa05146 | 0.83012007 |
88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80480094 |
89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75946103 |
90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75449702 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73443351 |
92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67833176 |
93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67619061 |
94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64128346 |
95 | Phagosome_Homo sapiens_hsa04145 | 0.61740205 |
96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61626338 |
97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58917716 |
98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58648465 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.55997529 |
100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54462316 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53539697 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.51963436 |
103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51236950 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51235234 |
105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50633476 |
106 | Measles_Homo sapiens_hsa05162 | 0.50039765 |
107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45110415 |
108 | Hepatitis B_Homo sapiens_hsa05161 | 0.45054202 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44964444 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44606976 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39408923 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38053524 |
113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37771551 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36839913 |
115 | Shigellosis_Homo sapiens_hsa05131 | 0.34333320 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31183637 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29403446 |
118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28658692 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.26072032 |
120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25474613 |
121 | Prion diseases_Homo sapiens_hsa05020 | 0.24954529 |
122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16243112 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08783523 |
124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07108161 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06024555 |
126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.03980185 |
127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.00954968 |
128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1384427 |
129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1325341 |
130 | Hepatitis C_Homo sapiens_hsa05160 | -0.1240254 |
131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1203141 |
132 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1201565 |
133 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1134490 |
134 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.1125060 |
135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1071020 |
136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1025888 |
137 | Axon guidance_Homo sapiens_hsa04360 | -0.0946575 |
138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0921280 |
139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0830264 |
140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0733198 |
141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0698734 |
142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0485204 |
143 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0454488 |
144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0348180 |
145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0294197 |
146 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0283133 |
147 | Mineral absorption_Homo sapiens_hsa04978 | -0.0159967 |
148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.0018211 |